Halo Labs Reports Record Monthly Revenue of Approximately US$2.6 Million (CDN $3.4 Million) In the Shortened Month of February

California Operations Account for Over 60% Of Revenue

CATHEDRAL CITY, Calif. & TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTC:
AGEEF, Germany: A9KN) is pleased to announce that the Company achieved
another record setting revenue month in February 2019 of approximately
US$2.6MM (CDN $3.4MM). This figure is estimated, unaudited and
approximate.

California operations now represent over 60% of the Company’s monthly
revenues. The recently announced Cannus contract is expected to add
monthly revenues of approximately US$1 million (CDN$1.32 million) with
initial shipments starting in March. Halo anticipates California’s
revenue contribution to continue to grow as a percentage of overall
Company revenue.

Kiran Sidhu, CEO commented: “We are laser focused on the massive
opportunity we believe we have in the state of California.”

ABOUT HALO LABS

Halo is a cannabis extraction company that develops and manufactures
quality cannabis oils and concentrates, which are the fastest growing
segments in the cannabis industry. Halo has expertise in all major
cannabis manufacturing processes, leveraging proprietary processes and
products, and has produced over 3.0M grams of oils and concentrates
since inception. The forward-thinking company is led by a strong
management team with deep industry knowledge and blue-chip experience.
The Company is currently operating in California, Nevada and Oregon as
well as Lesotho Africa through a strategic partnership. With a
consumer-centric focus, Halo will continue to market innovative branded
and private label products across multiple product categories.

For further information regarding Halo, see Halo’s disclosure documents
on SEDAR at www.sedar.com.

Cautionary Note Regarding Forward-Looking Information and
Statements

This press release contains certain “forward-looking information”
within the meaning of applicable Canadian securities legislation and may
also contain statements that may constitute “forward-looking statements”
within the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. Such forward-looking
information and forward-looking statements are not representative of
historical facts or information or current condition, but instead
represent only Halo’s beliefs regarding future events, plans or
objectives, many of which, by their nature, are inherently uncertain and
outside of Halo’s control. Generally, such forward-looking information
or forward-looking statements can be identified by the use of
forward-looking terminology such as “plans”, “expects” or “does not
expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”,
“intends”, “anticipates” or “does not anticipate”, or “believes”, or
variations of such words and phrases or may contain statements that
certain actions, events or results “may”, “could”, “would”, “might” or
“will be taken”, “will continue”, “will occur” or “will be achieved”.
The forward-looking information and forward-looking statements contained
herein may include, but is not limited to, information concerning the
Company’s second facility in Cathedral City, the future prospects of the
Company, the production capacity of the Company’s current facility in
Cathedral City, the Company’s prospects for future partnerships with
Canadian and European entities and the expected timing of the launch of
DabTabs™ in various markets.

By identifying such information and statements in this manner, Halo
is alerting the reader that such information and statements are subject
to known and unknown risks, uncertainties and other factors that may
cause the actual results, level of activity, performance or achievements
of Halo to be materially different from those expressed or implied by
such information and statements. In addition, in connection with the
forward-looking information and forward-looking statements contained in
this press release, Halo has made certain assumptions.

Among others, the key factors that could cause actual results to
differ materially from those projected in the forward-looking
information and statements are the following: adverse changes in
applicable laws; adverse changes to suppliers and other third parties
with which the Company does business, changes in general economic,
business and political conditions, including changes in the financial
markets and the other risks disclosed in the most recent management
information circular (including the documents incorporated by reference
therein). Should one or more of these risks, uncertainties or other
factors materialize, or should assumptions underlying the
forward-looking information or statements prove incorrect, actual
results may vary materially from those described herein as intended,
planned, anticipated, believed, estimated or expected.

Although Halo believes that the assumptions and factors used in
preparing, and the expectations contained in, the forward-looking
information and statements are reasonable, undue reliance should not be
placed on such information and statements, and no assurance or guarantee
can be given that such forward-looking information and statements will
prove to be accurate, as actual results and future events could differ
materially from those anticipated in such information and statements.
Key assumptions used herein are that the development of the Company’s
second facility in Cathedral City will not be subject to any unexpected
costs or delays, that the current facility in Cathedral City will be
able to operate at full capacity, that the Company’s discussions with
potential partners, both domestic and international, will progress as
expected and that the launch of the DabTab™ product line will not
be subject to any unexpected costs or delays. The forward-looking
information and forward-looking statements contained in this press
release are made as of the date of this press release, and Halo does not
undertake to update any forward-looking information and/or
forward-looking statements that are contained or referenced herein,
except in accordance with applicable securities laws. All subsequent
written and oral forward-looking information and statements attributable
to Halo or persons acting on its behalf is expressly qualified in its
entirety by this notice.

Contacts

Halo Labs
Investor Relations
info@halocanna.com